Vote Scores
Filings read through

How funds voted at Aerovate Therapeutics, Inc.

Filers reporting
65, year to 30 June 2026
Latest meeting on file
Meetings on file
3

In the year to 30 June 2026, 65 filers on Form N-PX reported votes at Aerovate Therapeutics, Inc.. The votes fall in one meeting. The figures count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting. Filers gave 185 marks to the ballot items, each with or against management. 96.2% of the marks are with management.

In the year to 30 June 2026, no say-on-pay item is on file for Aerovate Therapeutics, Inc.. So there is no figure to give.

By filers reporting in the year to 30 June 2026, Aerovate Therapeutics, Inc. was number 4,555 of 11,972 companies with a page and votes in that year. The number of filers reporting at Aerovate Therapeutics, Inc. rose by 62.5% from the year to 30 June 2025 to the year to 30 June 2026. At the companies on this site with filers in both years, the total of filers reporting rose by 6.0%. In all seasons on file, category SECTION 14A SAY-ON-PAY VOTES is 0.1% of the vote records at Aerovate Therapeutics, Inc.. At all companies on this site, it is 12.3%.

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

Since the last update

The site has recorded no change in the tracked figures of this page.

Tracked: the meetings on file and the date of the latest meeting. All recorded changes

The ballot of 9 Jun 2026

64 filers reported votes at this meeting in the year to 30 June 2026. The items are in ballot order: the company's items first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting. The meeting page has the split by reported shares and a CSV file.

  1. Item 1: Director elections

    2 nominees. 77.1% of the reported votes are for. 32 filers withheld from or voted against at least one nominee.

    218 vote records from 63 filers. 0 of the 62 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 28 fund families
    • For 11
    • Split or no vote 17
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    1 vote record from 1 filer. No filer marked the item for or against management. 1 filer gave no management mark.

  3. Item 3: Audit-related items (auditor ratification)

    109 vote records from 63 filers. 0 of the 62 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 28 fund families
    • For 27
    • Split or no vote 1
  4. Item 4: CORPORATE GOVERNANCE: management items

    The company's items in this category are shown together, because filers word and number them differently.

    108 vote records from 62 filers. 7 of the 61 filers that marked the item voted against management. 1 filer gave no management mark.

    • Positions of 28 fund families
    • For 22
    • Against 5
    • Split or no vote 1
    • Against management 5

Positions of the fund families at the meeting of 9 Jun 2026

No single ballot item here has the position of a fund family. Director elections and grouped items are not in this table.

Every meeting on file

Meetings of Aerovate Therapeutics, Inc., from Form N-PX filings, newest firstA meeting with 20 or more reporting filers has its own page. Dates up to three days apart count as one meeting.
MeetingSeasonFilers reportingItemsFilers against management on say-on-pay
year to 30 June 2026644not reported
year to 30 June 2025396not reported
year to 30 June 2024592not reported

Say-on-pay, season by season

Say-on-pay at Aerovate Therapeutics, Inc.: filers reporting on Form N-PXThe share of filers, and of the shares they reported, that voted against management.
SeasonFilers reportingFilers against managementReported shares against management
year to 30 June 202665not reportednot reported
year to 30 June 202540not reportednot reported
year to 30 June 202460not reportednot reported
Aerovate Therapeutics, Inc. and the median of companies on this site, year to 30 June 2026
Say-on-payThis companyMedian of companies on this site
Filers against managementnot reported6.6%
Reported shares against managementnot reported2.9%

The median covers 3,799 companies. Each has a say-on-pay item that 20 or more filers reported. The two figures are not a grade. The median is a reference only.

Vote records at Aerovate Therapeutics, Inc. by category, every seasonThe category is the one each filer chose.
CategoryVote recordsShare
DIRECTOR ELECTIONS60042.1%
SECTION 14A SAY-ON-PAY VOTES10.1%
AUDIT-RELATED26818.8%
EXTRAORDINARY TRANSACTIONS1198.4%
CAPITAL STRUCTURE1379.6%
COMPENSATION1258.8%
CORPORATE GOVERNANCE17512.3%

The record at the SEC

Each link loaded on .

Cite this page

Vote Scores. How funds voted at Aerovate Therapeutics, Inc.. https://votescores.com/company/aerovate-therapeutics-inc/. Source: SEC EDGAR, Form N-PX and N-PX/A filings read through .

Questions

How many meetings of Aerovate Therapeutics, Inc. are on file?
3 meetings are on file, from 5 Jun 2024 to 9 Jun 2026. 3 meetings have 20 or more reporting filers and have their own page.
Did filers report proposals from security holders at Aerovate Therapeutics, Inc.?
Not enough filers reported a proposal from security holders for the site to show one in the year to 30 June 2026. The ballot shows the items that filers did report.
Is this the meeting result?
No. The figures count the filers that report on Form N-PX and the shares they reported. Other holders are not in the count. Aerovate Therapeutics, Inc. reports the result of a vote on Form 8-K.
How does the site group meetings and names?
Filers type company names and meeting dates themselves. The site groups spellings of one company name. It treats meeting dates up to three days apart as one meeting. The data runs through 13 Nov 2026.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Aerovate Therapeutics, Inc., grouped by company. The name is the most common spelling among filers. The filers wrote the filings. Filings read through .